Does LUMASIRAN Cause Hyperoxalaemia? 8 Reports in FDA Database

Q: Does LUMASIRAN cause Hyperoxalaemia?

8 reports of Hyperoxalaemia have been filed with the FDA for LUMASIRAN, representing 2.9% of all LUMASIRAN adverse event reports.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hyperoxalaemia have been filed in association with LUMASIRAN (OXLUMO). This represents 2.9% of all adverse event reports for LUMASIRAN.

Reports of Hyperoxalaemia with LUMASIRAN

2.9%

of all LUMASIRAN reports

Deaths

Hospitalizations

How Dangerous Is Hyperoxalaemia From LUMASIRAN?

Of the 8 reports.

Is Hyperoxalaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LUMASIRAN. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does LUMASIRAN Cause?

Renal transplant (38) Nephrolithiasis (22) Drug ineffective (15) Hospitalisation (15) Urine oxalate increased (14) Acute kidney injury (11) Liver transplant (11) Laboratory test abnormal (9) Product dose omission issue (9) Death (8)

What Other Drugs Cause Hyperoxalaemia?

Which LUMASIRAN Alternatives Have Lower Hyperoxalaemia Risk?

LUMASIRAN vs LUMATEPERONE LUMASIRAN vs LUMIGAN LUMASIRAN vs LUPRON DEPOT LUMASIRAN vs LUPRON DEPOT-PED LUMASIRAN vs LURASIDONE

LUMASIRAN Full Profile All Hyperoxalaemia Reports All Drugs Causing Hyperoxalaemia LUMASIRAN Demographics